However, high serum FGF21 levels are found in obese subjects (11,12), it can be increased in subjects with other insulin resistant states such as dyslipidemia and coronary artery disease (13) non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (10-16). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.